Vion Pharmaceuticals Inc. 3rd Quar Sept. 30:
2000 1999
Revenue $368,092 $286,936
Net income (3,245,890) (2,333,077)
Avg shrs 25,804,736 15,550,930
Shr earns
Net income (.13) (.16)
9 Months:
Revenue 628,780 260,880
Net income (9,734,449) (8,856,385)
Avg shrs 23,455,570 14,921,896
Shr earns
Net income (.42) (.59)
Figures in parentheses are losses.
Vion Pharmaceuticals Inc. (VION) said its wider results were d primarily due to increased research and development expenses and increased general and administrative expenses, which were partially offset by increased interest income generated from additional cash resources.
Vion is a biopharmaceutical company. Company Web site: vionpharm.com |
